Live feed08:00:00·4mPRReleasevia QuantisnowEnveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 SeriesByQuantisnow·Wall Street's wire, on your screen.ENVB· Enveric Biosciences Inc.Health Care
